IMPACT Medicom
合計時間：
14 h 25 min
Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH
IMPACT Medicom
14:53
Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL
IMPACT Medicom
19:42
ASH 2024: Updates on CLL
IMPACT Medicom
26:34
Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape
IMPACT Medicom
17:37
Highlights from EHA 2024 - Updates on the Treatment of CLL
IMPACT Medicom
42:13
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL
IMPACT Medicom
16:33
Cutting Edge Advances in the Treatment of Lung Cancer
IMPACT Medicom
15:13
Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers
IMPACT Medicom
41:28
Immunotherapy for Kidney Transplant Patients with Skin Cancer
IMPACT Medicom
21:32
Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective
IMPACT Medicom
24:11
LIVE FROM ASH 2023: Isa-CYBORD induction chemotherapy in newly diagnosed, transplant eligible MM
IMPACT Medicom
16:58
Live from ASH 2023: Dr Brown Discusses Updated Results of the ALPINE Trial in CLL
IMPACT Medicom
13:48
First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on 1L LA/mUC
IMPACT Medicom
32:28
First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion
IMPACT Medicom
26:41
First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion
IMPACT Medicom
08:07
First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment
IMPACT Medicom
14:52
First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs
IMPACT Medicom
10:38
Precision Medicine Series: Ep14: External Quality Assurance in Biomarker Testing
IMPACT Medicom
39:04
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP4: Hyperglycemia
IMPACT Medicom
29:52
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP1: Introduction to EV
IMPACT Medicom
16:05
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP2: Skin Reactions
IMPACT Medicom
30:08
Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP3: Peripheral Neuropathy
IMPACT Medicom
22:47
Live from CCOLD - Treatment of CLL
IMPACT Medicom
30:40
Live from CCOLD: Dr Davids Discusses the ALPINE Trial in CLL
IMPACT Medicom
17:05
Precision Medicine Series: Ep13: Biomarkers in Endometrial Cancer
IMPACT Medicom
35:53
Highlights from ASH: Canadian Perspective on the ALPINE Trial in CLL
IMPACT Medicom
15:19
ASH Highlights - ALPINE Trial Shows Improved Efficacy and Safety Profile of Zanubrutinib vs Ibrutinib in CLL
IMPACT Medicom
14:34
Emerging Treatments for Advanced, Unresectable Biliary Tract Cancer
IMPACT Medicom
14:56
Precision Medicine in Oncology Podcast Series: Ep12. Biomarkers for the treatment of breast cancer
IMPACT Medicom
37:49
COVID-19 Pre-Exposure Prophylaxis - Ep4: Protecting Immunocompromised Patients
IMPACT Medicom
22:29
COVID-19 Pre-Exposure Prophylaxis - Ep3: Patients with Cancer
IMPACT Medicom
35:21
COVID-19 Pre-Exposure Prophylaxis - Ep2: Patients with Hematological Malignancies
IMPACT Medicom
14:57
COVID-19 Pre-Exposure Prophylaxis - Ep1: A pharmacist perspective (French)
IMPACT Medicom
21:57
Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301
IMPACT Medicom
12:57
Immunotherapy for Cervical Cancer
IMPACT Medicom
18:56
Immunotherapy in HNSCC Series: Ep 3 - Role of the Medical Oncologist
IMPACT Medicom
12:33
Precision Medicine in Oncology: Ep.11. Selection and use of PARP inhibitors for first-line maintenance treatment in ovarian cancer
IMPACT Medicom
15:53
Immunotherapy in HNSCC Series: Ep 2 - Perspectives from Surgical Oncology
IMPACT Medicom
14:13
Immunotherapy in HNSCC Series: Ep 1 - PD-L1 testing
IMPACT Medicom
12:45
Triple Negative Breast Cancer: Immunotherapies and Biomarkers
IMPACT Medicom
16:01
